← Back to Search

Behavioral Intervention

Online Quit-Smoking Training for Preventing Smoking Relapse

N/A
Waitlist Available
Led By Myra Muramoto, MD, MPH
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weekly data collected months 1-6; bi-weekly data collected months 7-12; data collected at 3-, 6-, 9-, and 12-months post-randomization
Awards & highlights

Study Summary

This trial looks at how training affects newly quit smokers and their social network's support for quitting.

Who is the study for?
This trial is for adults over 18 who smoke cigarettes, have quit smoking for 14-45 days, and are proficient in English. Participants need Internet access and must be willing to send weekly texts, complete online surveys, self-collect a blood sample, and possibly do an interview. They can't have had cessation training in the past 2 years.Check my eligibility
What is being tested?
The study tests the Helpers Stay Quit online training program's effectiveness on maintaining non-smoking status among recent quitters and its impact on their social interactions regarding smoking habits.See study design
What are the potential side effects?
Since this trial involves an educational program rather than medication or medical procedures, traditional physical side effects are not expected. However, participants may experience stress or frustration related to behavior change.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weekly data collected months 1-6; bi-weekly data collected months 7-12; data collected at 3-, 6-, 9-, and 12-months post-randomization
This trial's timeline: 3 weeks for screening, Varies for treatment, and weekly data collected months 1-6; bi-weekly data collected months 7-12; data collected at 3-, 6-, 9-, and 12-months post-randomization for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
7-day and 30-day abstinence from using combustible tobacco at 12 months post-randomization
7-day and 30-day abstinence from using combustible tobacco at 6 months post-randomization
Secondary outcome measures
7-day and 30-day abstinence from using combustible tobacco at 3 months and 9 months post-randomization
Biochemical confirmation of abstinence at 6 and 12 months on a subsample
Number of helping conversations offered
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Helpers Stay Quit TrainingExperimental Treatment1 Intervention
Research participants randomized to the experimental arm will receive the on-line Helpers Stay Quit training which provides training on how to help others quit smoking.
Group II: Usual CareActive Control1 Intervention
Research participants randomized to the arm without intervention will receive Quitline usual care. They will be contacted for assessment of abstinence at 7 months after enrollment in services. If the participant has relapsed, the Quitline will attempt to re-engage the participant in cessation services (telephone and/or web-based).

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,732 Previous Clinical Trials
2,142,643 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,658 Previous Clinical Trials
40,923,549 Total Patients Enrolled
Myra Muramoto, MD, MPHPrincipal InvestigatorUniversity of Colorado School of Medicine

Media Library

Helpers Stay Quit Training (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05641974 — N/A
Smoking/Cigarette Smoking Research Study Groups: Helpers Stay Quit Training, Usual Care
Smoking/Cigarette Smoking Clinical Trial 2023: Helpers Stay Quit Training Highlights & Side Effects. Trial Name: NCT05641974 — N/A
Helpers Stay Quit Training (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05641974 — N/A
Smoking/Cigarette Smoking Patient Testimony for trial: Trial Name: NCT05641974 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research project accept elderly individuals as participants?

"Eligibility requirements for this clinical trial necessitates that applicants be between 18 and 99 years of age."

Answered by AI

Is my profile compatible with participating in this medical trial?

"Qualified participants for this research must be habitual smokers and between 18-99 years old. There is a target of 940 enrollees in total."

Answered by AI

Is this medical experiment currently accepting participants?

"Clinicaltrials.gov data indicates that this medical trial is not presently looking for participants, with the study having started on December 12th 2022 and its latest update being January 19th 2023. However, there are 1098 other clinical trials currently recruiting patients."

Answered by AI

What results is this experiment attempting to demonstrate?

"This clinical trial seeks to quantify 7-day and 30-day abstinence from combustible tobacco use at 12 months post randomization, using self-reported data collected 6 months after the initial randomisation. Other objectives include calculating time to first relapse - defined as participant reported number of days (if any) they smoked combustible tobacco within a specified timeframe – in addition to determining 7/30 day abstention rates 3 & 9 months later. Lastly, it will measure how many helping conversations were offered by participants during the study period."

Answered by AI

Who else is applying?

What state do they live in?
Colorado
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
0
What site did they apply to?
University of Colorado Anschutz

Why did patients apply to this trial?

I've had a difficult time quitting smoking. I go back to smoking after a month or two.
PatientReceived no prior treatments
~582 spots leftby Jun 2026